While endocrinologists and internists still dominate prescribing, nondiabetes specialists have increased GLP1 prescribing by 900% since 2020, signaling a fundamental shift in perception and adoption as audiences expand beyond traditional prescribers
Postoperative aspiration pneumonia among adults using GLP-1 receptor agonists
Ozempic: vad r det och hur fungerar det
Among the 58% of adults who say they want to lose weight, nearly one-third (32%) expect to start a prescription GLP-1 drug in 2026, which translates to an estimated 48 million American adults including 9% who say they definitely will and 23% who say they probably will
The pooled STEP analysis found the same thing: gastrointestinal events were transient and clustered during or shortly after each step up
Oberg recognizes that joining a GLP-1 Treatments, Semaglutide or Tirzepatide medical weight loss program in Scottsdale, AZ, is a life-changing process